Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.

Source:http://linkedlifedata.com/resource/pubmed/id/14638501

Download in:

View as

General Info

PMID
14638501